ImmuneWatch

Antwerpen ·KBO/BCE: BE 0774.472.942

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-12.9%	55.0%	better than 15% of 174 sector peers
Net result	€-81k	€16k	better than 11% of 174 sector peers
Equity	€-39k	€70k	better than 6% of 174 sector peers
Gross operating margin	€110k	€41k	better than 77% of 175 sector peers
Staff costs	€51k	€58k	higher than 44% of 38 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€300k
Fixed assets	21/28	€14k
Intangible fixed assets	21	€12k
Tangible fixed assets	22/27	€2k
Current assets	29/58	€286k
Amounts receivable within one year	40/41	€32k
Cash & bank	54/58	€222k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€300k
Equity	10/15	€-39k
Contributions / capital	10/11	€232k
Accumulated profits (losses)	14	€-270k
Amounts payable	17/49	€339k
Amounts payable after one year	17	€15k
Amounts payable within one year	42/48	€43k
Trade debts payable within one year	44	€36k
Income statement
Gross operating margin	9900	€110k
Operating result	9901	€-83k
Financial income	75	€0
Financial charges	65	€2k
Result before taxes	9903	€-85k
Income taxes	67/77	€-4k
Net result for the period	9904	€-81k
Result to be appropriated	9905	€-81k

Summary